Have a personal or library account? Click to login
Original article. Potential risk of dihydroergotamine causing medicationoveruse headache: preclinical evidence Cover

Original article. Potential risk of dihydroergotamine causing medicationoveruse headache: preclinical evidence

Asian Biomedicine
Volume 8 (2014): Issue 3 (June 2014)
By: Suteera Vibulyaseck,  Saknan Bongsebandhu-phubhakdi,  Supang Maneesri le Grand and  Anan Srikiatkhachorn  
Open Access
|Feb 2017
DOI: https://doi.org/10.5372/1905-7415.0802.296 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Journal RSS Feed
Language: English
Page range: 323 - 331
Published on: Feb 4, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
Cortical excitability,
cortical spreading depression,
CSD,
c-Fos expression,
dihydroergotamine,
DHE,
medication-overuse headache,
MOH,
trigeminal nociception
Related subjects:
Medicine,
Assistive professions, nursing,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other

© 2017 Suteera Vibulyaseck, Saknan Bongsebandhu-phubhakdi, Supang Maneesri le Grand, Anan Srikiatkhachorn, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 8 (2014): Issue 3 (June 2014)Next article